Radiopharm Theranostics Equity 2024

Equity Details

Analyzing Radiopharm Theranostics's Equity

Radiopharm Theranostics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Radiopharm Theranostics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Radiopharm Theranostics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Radiopharm Theranostics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Radiopharm Theranostics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Radiopharm Theranostics stock

What is the equity of Radiopharm Theranostics this year?

Radiopharm Theranostics has equity of 44.38 M AUD this year.

What was the equity of Radiopharm Theranostics compared to the previous year?

The equity of Radiopharm Theranostics has increased/decreased by -29.51% decreased compared to the previous year.

What impact does a high equity have on investors of Radiopharm Theranostics?

A high equity is advantageous for investors of Radiopharm Theranostics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Radiopharm Theranostics?

A low equity can be a risk for investors of Radiopharm Theranostics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Radiopharm Theranostics affect the company?

An increase in equity of Radiopharm Theranostics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Radiopharm Theranostics affect the company?

A reduction in equity of Radiopharm Theranostics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Radiopharm Theranostics?

Some factors that can affect the equity of Radiopharm Theranostics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Radiopharm Theranostics so important for investors?

The equity of Radiopharm Theranostics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Radiopharm Theranostics take to change the equity?

To change equity, Radiopharm Theranostics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Radiopharm Theranostics pay?

Over the past 12 months, Radiopharm Theranostics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Radiopharm Theranostics is expected to pay a dividend of 0 AUD.

What is the dividend yield of Radiopharm Theranostics?

The current dividend yield of Radiopharm Theranostics is .

When does Radiopharm Theranostics pay dividends?

Radiopharm Theranostics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Radiopharm Theranostics?

Radiopharm Theranostics paid dividends every year for the past 0 years.

What is the dividend of Radiopharm Theranostics?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Radiopharm Theranostics located?

Radiopharm Theranostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Radiopharm Theranostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Radiopharm Theranostics from 7/11/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 7/11/2024.

When did Radiopharm Theranostics pay the last dividend?

The last dividend was paid out on 7/11/2024.

What was the dividend of Radiopharm Theranostics in the year 2023?

In the year 2023, Radiopharm Theranostics distributed 0 AUD as dividends.

In which currency does Radiopharm Theranostics pay out the dividend?

The dividends of Radiopharm Theranostics are distributed in AUD.